New Leaf Venture Partners, L.L.C. - DICE THERAPEUTICS INC ownership

DICE THERAPEUTICS INC's ticker is and the CUSIP is 23345J104. A total of 164 filers reported holding DICE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 2.30 and the average weighting 0.6%.

Quarter-by-quarter ownership
New Leaf Venture Partners, L.L.C. ownership history of DICE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$17,268,857
+62.2%
371,6930.0%14.83%
+68.5%
Q1 2023$10,649,004
-8.2%
371,6930.0%8.80%
+4.8%
Q4 2022$11,596,822
+2.7%
371,693
-33.2%
8.40%
+25.3%
Q3 2022$11,290,000
+30.7%
556,6930.0%6.70%
+19.7%
Q2 2022$8,640,000
-18.9%
556,6930.0%5.60%
+6.6%
Q1 2022$10,650,000
-24.4%
556,6930.0%5.25%
+2.8%
Q4 2021$14,090,000
-22.7%
556,6930.0%5.10%
-2.9%
Q3 2021$18,232,000556,6935.26%
Other shareholders
DICE THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Northpond Ventures, LLC 3,292,871$102,737,57555.73%
Sands Capital Ventures, LLC 2,748,970$85,76823.49%
OUP Management Co., LLC 268,346$8,372,39513.67%
New Leaf Venture Partners, L.L.C. 371,693$11,596,8228.40%
RA Capital Management 6,848,911$213,686,0234.33%
VR Adviser, LLC 819,000$25,552,8004.30%
SVB FINANCIAL GROUP 42,358$1,321,5703.61%
Logos Global Management LP 660,000$20,592,0002.41%
Deep Track Capital, LP 1,734,143$54,105,2622.27%
Samsara BioCapital, LLC 202,773$6,326,5181.36%
View complete list of DICE THERAPEUTICS INC shareholders